This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Next revision Both sides next revision | ||
eyel [2023/12/04 13:11] trynke |
eyel [2023/12/04 13:13] trynke |
||
---|---|---|---|
Line 3: | Line 3: | ||
Eyelife is one of Lifelines' [[additional assessments]].\\ | Eyelife is one of Lifelines' [[additional assessments]].\\ | ||
This assessment was a collaboration between Lifelines and the UMCG [[https://www.rug.nl/research/opthalmology/|Department of Opthalmology]].\\ | This assessment was a collaboration between Lifelines and the UMCG [[https://www.rug.nl/research/opthalmology/|Department of Opthalmology]].\\ | ||
- | The goal of the assessment was to quantify ocular health in the general ageing population, in particular the prevalence of [[https://en.wikipedia.org/wiki/Glaucoma|glaucoma]], using an extensive [[https://en.wikipedia.org/wiki/Eye_examination|eye exam]]. In addition, the goal was to determine if a population-based screening of early glaucoma will be feasible if performed in people genetically predisposed to develop the disease. | + | The goal of the assessment was to quantify ocular health in the general ageing population, in particular the prevalence of [[https://en.wikipedia.org/wiki/Glaucoma|glaucoma]], using an extensive [[https://en.wikipedia.org/wiki/Eye_examination|eye exam]]. In addition, the goal was to determine if a population-based screening of early glaucoma will be feasible if performed in people genetically predisposed to develop the disease ((Neustaeter, A. et al. (2021) Genetic pre-screening for glaucoma in population-based epidemiology: protocol for a double-blind prospective screening study within Lifelines (EyeLife); BMC Ophthalmol 21(1):18)) |
===== Background ===== | ===== Background ===== |